Literature DB >> 3986201

Glucose transport across the basal plasma membrane of human placental syncytiotrophoblast.

L W Johnson, C H Smith.   

Abstract

Transfer of glucose from maternal to fetal circulations requires transport across both the microvillous (maternal-facing) and basal (fetal-facing) plasma membranes of the placental syncytium. We have previously reported transport properties of the microvillous membrane and we now report those of the basal membrane. Basal plasma membrane vesicles were prepared by selective sonication and density gradient centrifugation. Glucose or glucose analogues were rapidly transported across these membranes by facilitated diffusion. Transport was inhibited by cytochalasin B, phloretin and phloridzin. L-Glucose at 1 mM was transferred at only 1/700 of the rate of D-glucose, which indicated an insignificant nonspecific diffusion component. Transport was independent of sodium gradients, and kinetic studies under equilibrium-exchange conditions demonstrated a Km of 23 mM. Competition studies demonstrated that aldohexoses in the C-1 chair conformation were the preferred substrates. Placental steroids estriol and progesterone inhibited transport. In contrast to other polarized epithelia, the basal and microvillous membranes of the human placental syncytium possess transport systems with similar properties. Thus, the directionality and rate of transfer of glucose across the intact syncytium are likely to be direct functions of the materno-fetal concentration gradient and the total transport capacities of the two plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986201     DOI: 10.1016/0005-2736(85)90472-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi.

Authors:  K Takata; T Kasahara; M Kasahara; O Ezaki; H Hirano
Journal:  Cell Tissue Res       Date:  1992-03       Impact factor: 5.249

2.  A theoretical model of glucose transport suggests symmetric GLUT1 characteristics at placental membranes.

Authors:  Efrath Barta; Arieh Drugan
Journal:  J Membr Biol       Date:  2014-06-04       Impact factor: 1.843

3.  Influence of estrogenic pesticides on membrane integrity and membrane transfer of monosaccharide into the human red cell.

Authors:  R L Ingermann
Journal:  Bull Environ Contam Toxicol       Date:  1989-09       Impact factor: 2.151

4.  Placental glucose transporter gene expression and metabolism in the rat.

Authors:  J Zhou; C A Bondy
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 5.  Placental glucose transfer and fetal growth.

Authors:  Marc U Baumann; Sylvie Deborde; Nicholas P Illsley
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

6.  Sulphate transport into vesicles prepared from human placental brush border membranes: inhibition by trace element oxides.

Authors:  C A Boyd; D B Shennan
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

7.  Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.

Authors:  L F Barros; J C Bustamante; D L Yudilevich; S M Jarvis
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

8.  Changes in lipid composition and fluidity of human placental basal membrane and modulation of bilayer protein functions with progress of gestation.

Authors:  A Sen; P K Ghosh; M Mukherjea
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

9.  Bidirectional placental transfer ('leak') of L-glucose in control and diabetic rats.

Authors:  C R Thomas; C Lowy
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

10.  Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells.

Authors:  Nicoletta Di Simone; Fiorella Di Nicuolo; Daniela Marzioni; Mario Castellucci; Maurizio Sanguinetti; Silvia D'lppolito; Alessandro Caruso
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.